Concurrently, research has incorporated therapeutic interventions: a fractal-fractional model23 confirms the potent efficacy of a single-dose anti-PD-L1 immunotherapy in significantly clearing tumor cells, and another simulated cetuximab treatment, capturing its dynamic impact on the tumor microenvironment24. Here, CD274 is linked to neoplasm.